CONMED Corporation (CNMD) Market Cap & Valuation Ratios
CONMED Corporation (CNMD) has a market cap of $1.5B, a trailing P/E of 26.6 and a price-to-sales ratio of 1.1, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CNMDCONMED CorporationFollow CNMD — free
—
Price chart with a free account
- Market cap
- 1.5B
- P/E TTM
- 26.6
- Dividend yield
- 1.2%
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Peers
medical devices · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| CNMD | 1.5 | 26.6 | 1.7 | 14.0 | 9.1% | +3% | 8% | 4% |
| ESTA | 1.9 | — | 8.5 | — | -2.2% | +39% | -8% | -9% |
| BFLY | 1.8 | — | 14.9 | — | -1.6% | +28% | -71% | -106% |
| ATEC | 1.7 | — | 2.7 | 77.8 | 0.1% | +19% | -6% | -11% |
| NVCR | 1.7 | — | 2.6 | — | -1.5% | +11% | -22% | -42% |
| BVS | 1.3 | — | 2.5 | 14.3 | 7.5% | +3% | 10% | 10% |
| ENOV | 1.2 | — | 1.1 | 8.1 | 5.2% | +5% | -45% | -31% |
| TNDM | 1.2 | — | 1.3 | — | -2.2% | +4% | -4% | -9% |
| PRCT | 1.1 | — | 2.9 | — | -7.4% | +23% | -34% | -77% |
| AORT | 1.1 | — | 3.0 | 31.5 | -0.8% | +16% | 4% | 2% |
| IRMD | 1.1 | 47.9 | 12.0 | 35.6 | 2.2% | +11% | 32% | 51% |
| Median of these 10 | 47.9 | 2.8 | 31.5 | -1.1% | +14% | -7% | -10% |
P/E 26.6 vs. a peer median of 47.9; EV/Sales 1.7 vs. 2.8. CNMD's own P/E sits at the 52nd percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesCONMED Corporation — questions
- What is CONMED Corporation's market cap?
- $1.5B.
- What is CONMED Corporation's P/E ratio?
- 26.6 on trailing twelve-month earnings to 2026-06-30.
- What is CONMED Corporation's price-to-sales ratio?
- 1.1.
Every figure on this page comes from CONMED Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.